TBPH
Theravance Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.78
-0.11 ▼ -0.79%
🌙 3월 13일 4:04 PM ET (한국 3/14 05:04)
$13.78
+0.00 +0.00%
| Index | RUT | P/E | 24.5 | EPS (ttm) | 0.56 | Insider Own | 6.62% | Shs Outstand | 0.05B | Perf Week | 1.55% |
| Market Cap | 0.70B | Forward P/E | 6.91 | EPS next Y | 1.23% | Insider Trans | -0.92% | Shs Float | 0.05B | Perf Month | -29.37% |
| Enterprise Value | 0.41B | PEG | - | EPS next Q | 1.09 | Inst Own | 98.94% | Short Float | 10.06% | Perf Quarter | -21.75% |
| Income | 0.03B | P/S | 8.69 | EPS this Y | 271.18% | Inst Trans | 4.44% | Short Ratio | 8.05 | Perf Half Y | 0.58% |
| Sales | 0.08B | P/B | 3 | EPS next 5Y | - | ROA | 7.61% | Short Interest | 4.76M | Perf YTD | -26.35% |
| Book/sh | 4.59 | P/C | 2.12 | EPS past 3/5Y | 26.18% 22.95% | ROE | 14.03% | 52W High | -34.47% ($21.03) | Perf Year | 48.49% |
| Cash/sh | 6.51 | P/FCF | 2.87 | Sales past 3/5Y | 5.19% -2.59% | ROIC | 11.02% | 52W Low | 74.43% ($7.90) | Perf 3Y | 34.44% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 156.96% | Gross Margin | 93.15% | Volatility(W/M) | 3.96% 4.94% | Perf 5Y | -33.24% |
| Dividend TTM | - | EV/Sales | 5.14 | Sales Y/Y TTM | 27.12% | Oper. Margin | -43.72% | ATR (14) | 0.93 | Perf 10Y | -22.15% |
| Dividend Ex-Date | - | Quick Ratio | 9.48 | EPS Q/Q | 126.88% | Profit Margin | 36.53% | RSI (14) | 26.25 | Recom | 2.14 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.48 | Sales Q/Q | 18.51% | SMA20 | -17.4% ($16.68) | Beta | 0.19 | Target Price | $15.83 |
| Payout | - | Debt/Eq | 0.19 | Earnings | 11000000 | SMA50 | -25.2% ($18.42) | Rel Volume | 0.98 | Prev Close | $13.89 |
| Employees | 97 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | 154.73% 0.15% | SMA200 | -8.64% ($15.08) | Avg Volume(3M) | 0.59M | Price | $13.78 |
| IPO | 2014/5/16 | Option/Short | Yes/Yes | Trades | 6587 | Volume | 579,441 | Change | -0.79% |
뉴스 로딩 중...